Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-control... von Banerjee, Susana, Moore, Kathleen N, Colombo, Nicoletta, Scambia, Giovanni, Kim, Byoung-Gie, Oaknin, Ana, Friedlander, Michael, Lisyanskaya, Alla, Floquet, Anne, Leary, Alexandra, Sonke, Gabe S, Gourley, Charlie, Oza, Amit, González-Martín, Antonio, Aghajanian, Carol, Bradley, William H, Holmes, Eileen, Lowe, Elizabeth S, DiSilvestro, Paul

Volltext

Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0... von Coleman, Robert L, Prof, Brady, Mark F, Prof, Herzog, Thomas J, Prof, Sabbatini, Paul, Prof, Armstrong, Deborah K, Prof, Walker, Joan L, Prof, Kim, Byoung-Gie, Prof, Fujiwara, Keiichi, Prof, Tewari, Krishnansu S, Prof, O'Malley, David M, Prof, Davidson, Susan A, MD, Rubin, Stephen C, Prof, DiSilvestro, Paul, Prof, Basen-Engquist, Karen, Prof, Huang, Helen, MS, Chan, John K, MD, Spirtos, Nick M, MD, Ashfaq, Raheela, MD, Mannel, Robert S, MD

Volltext

Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer von Coleman, Robert L, Spirtos, Nick M, Enserro, Danielle, Herzog, Thomas J, Sabbatini, Paul, Armstrong, Deborah K, Kim, Jae-Weon, Park, Sang-Yoon, Kim, Byoung-Gie, Nam, Joo-Hyun, Fujiwara, Keiichi, Walker, Joan L, Casey, Ann C, Alvarez Secord, Angeles, Rubin, Steve, Chan, John K, DiSilvestro, Paul, Davidson, Susan A, Cohn, David E, Tewari, Krishnansu S, Basen-Engquist, Karen, Huang, Helen Q, Brady, Mark F, Mannel, Robert S

Volltext

Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial von Youn, Jin Won, Hur, Soo-Young, Woo, Jung Won, Kim, Yong-Man, Lim, Myong Cheol, Park, Sang Yoon, Seo, Sang Soo, No, Jae Hong, Kim, Byoung-Gie, Lee, Jae-Kwan, Shin, So Jin, Kim, Kyungun, Chaney, Marya F, Choi, Yoon-Jeong, Suh, You Suk, Park, Jong Sup, Sung, Young Chul

Volltext

Randomized, two‐arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in HRR ‐mutated, platinum‐resistant ovarian cancer: A substudy of KGOG 3045 von Kim, Yoo‐Na, Joung, Je‐Gun, Park, Eunhyang, Kim, Jae‐Weon, Lee, Jung Bok, Lim, Jinyeong, Kim, Sunghoon, Choi, Chel Hun, Kim, Hee Seung, Chung, Jongsuk, Kim, Byoung‐Gie, Lee, Jung‐Yun

Volltext

Reply to: Comments on “Randomized, two‐arm, non‐comparative phase 2 study of olaparib plus cediranib or durvalumab in HRR‐mutated, platinum‐resistant ovarian cancer: A substudy of... von Kim, Yoo‐Na, Joung, Je‐Gun, Park, Eunhyang, Kim, Jae‐Weon, Lee, Jung Bok, Lim, Jinyeong, Kim, Sunghoon, Choi, Chel Hun, Kim, Hee Seung, Chung, Jongsuk, Kim, Byoung‐Gie, Lee, Jung‐Yun

Volltext

Incorporation of pazopanib in maintenance therapy of ovarian cancer von du Bois, Andreas, Floquet, Anne, Kim, Jae-Weon, Rau, Joern, del Campo, Josep M, Friedlander, Michael, Pignata, Sandro, Fujiwara, Keiichi, Vergote, Ignace, Colombo, Nicoletta, Mirza, Mansoor R, Monk, Bradley J, Kimmig, Rainer, Ray-Coquard, Isabelle, Zang, Rongyu, Diaz-Padilla, Ivan, Baumann, Klaus H, Mouret-Reynier, Marie-Ange, Kim, Jae-Hoon, Kurzeder, Christian, Lesoin, Anne, Vasey, Paul, Marth, Christian, Canzler, Ulrich, Scambia, Giovanni, Shimada, Muneaki, Calvert, Paula, Pujade-Lauraine, Eric, Kim, Byoung-Gie, Herzog, Thomas J, Mitrica, Ionel, Schade-Brittinger, Carmen, Wang, Qiong, Crescenzo, Rocco, Harter, Philipp

Volltext

Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis von Yarmolinsky, James, Relton, Caroline L, Lophatananon, Artitaya, Muir, Kenneth, Menon, Usha, Gentry-Maharaj, Aleksandra, Walther, Axel, Zheng, Jie, Fasching, Peter, Zheng, Wei, Yin Ling, Woo, Park, Sue K, Kim, Byoung-Gie, Choi, Ji-Yeob, Park, Boyoung, Davey Smith, George, Martin, Richard M, Lewis, Sarah J

Volltext

Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer von Paik, E Sun, Heo, Eun Jin, Choi, Chel Hun, Kim, Jae‐Hoon, Kim, Jae‐Weon, Kim, Yong‐Man, Park, Sang‐Yoon, Lee, Jeong‐Won, Kim, Jong‐Won, Kim, Byoung‐Gie

Volltext

Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olapa... von Friedlander, Michael, Moore, Kathleen N, Colombo, Nicoletta, Scambia, Giovanni, Kim, Byoung-Gie, Oaknin, Ana, Lisyanskaya, Alla, Sonke, Gabe S, Gourley, Charlie, Banerjee, Susana, Oza, Amit, González-Martín, Antonio, Aghajanian, Carol, Bradley, William H, Liu, Joyce, Mathews, Cara, Selle, Frédéric, Lortholary, Alain, Lowe, Elizabeth S, Hettle, Robert, Flood, Emuella, Parkhomenko, Elena, DiSilvestro, Paul

Volltext

Cross-Activation of Regulatory T Cells by Self Antigens Limits Self-Reactive and Activated CD8+ T Cell Responses von Cho, Eunjung, Han, Seongeun, Eom, Hyeon Seok, Lee, Sang-Jin, Han, Chungyong, Singh, Rohit, Kim, Seon-Hee, Park, Bo-Mi, Kim, Byoung-Gie, Kim, Young H, Kwon, Byoung S, Nam, Ki Taek, Choi, Beom K

Volltext

Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer von Lee, Yoo-Young, Cho, Young-Jae, Shin, Sung-won, Choi, Changhoon, Ryu, Ji-Yoon, Jeon, Hye-Kyung, Choi, Jung-Joo, Hwang, Jae Ryoung, Choi, Chel Hun, Kim, Tae-Joong, Kim, Byoung- Gie, Bae, Duk-Soo, Park, Won, Lee, Jeong-Won

Volltext

Preoperative assessment of lymph node metastasis in endometrial cancer: A Korean Gynecologic Oncology Group study von Kang, Sokbom, Nam, Joo‐Hyun, Bae, Duk‐Soo, Kim, Jae‐Weon, Kim, Moon‐Hong, Chen, Xiaojun, No, Jae‐Hong, Lee, Jong‐Min, Kim, Jae‐Hoon, Watari, Hidemich, Kim, Seok Mo, Kim, Sung Hoon, Seong, Seok Ju, Kim, Ki Tae, Kim, Seung Cheol, Kim, Jong‐Hyeok, Lim, Myung‐Cheol, Lee, Jung‐Yun, Ryu, Sang‐Young, Yang, Bingyi, Kim, Byoung‐Gie

Volltext

Stratifying the risk of ovarian cancer incidence by histologic subtypes in the Korean Epithelial Ovarian Cancer Study (Ko‐EVE) von Sung, Soseul, Hong, Youjin, Kim, Byoung‐Gie, Choi, Ji‐Yeob, Kim, Jae Weon, Park, Sang‐Yoon, Kim, Jae‐Hoon, Kim, Yong‐man, Lee, Jong‐Min, Kim, Tae Jin, Park, Sue K.

Volltext

Prediction of final pathology depending on preoperative myometrial invasion and grade assessment in low-risk endometrial cancer patients: A Korean Gynecologic Oncology Group ancill... von Jang, Dong-Hoon, Lee, Hyun-Gyu, Lee, Banghyun, Kang, Sokbom, Kim, Jong-Hyeok, Kim, Byoung-Gie, Kim, Jae-Weon, Kim, Moon-Hong, Chen, Xiaojun, No, Jae Hong, Lee, Jong-Min, Kim, Jae-Hoon, Watari, Hidemich, Kim, Seok Mo, Kim, Sung Hoon, Seong, Seok Ju, Jeong, Dae Hoon, Kim, Yun Hwan

Volltext

Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer von Vergote, Ignace, González-Martín, Antonio, Fujiwara, Keiichi, Kalbacher, Elsa, Bagaméri, Andrea, Ghamande, Sharad, Lee, Jung-Yun, Banerjee, Susana, Maluf, Fernando Cotait, Lorusso, Domenica, Yonemori, Kan, Van Nieuwenhuysen, Els, Manso, Luis, Woelber, Linn, Westermann, Anneke, Covens, Allan, Hasegawa, Kosei, Kim, Byoung-Gie, Raimondo, Miriam, Bjurberg, Maria, Cruz, Felipe Melo, Angelergues, Antoine, Cibula, David, Barraclough, Lisa, Oaknin, Ana, Gennigens, Christine, Nicacio, Leo, Teng, Melinda Siew Leng, Whalley, Elizabeth, Soumaoro, Ibrahima, Slomovitz, Brian M.

Volltext

The anti-cancer effects of itraconazole in epithelial ovarian cancer von Choi, Chel Hun, Ryu, Ji-Yoon, Cho, Young-Jae, Jeon, Hye-Kyung, Choi, Jung-Joo, Ylaya, Kris, Lee, Yoo-Young, Kim, Tae-Joong, Chung, Joon-Yong, Hewitt, Stephen M., Kim, Byoung-Gie, Bae, Duk-Soo, Lee, Jeong-Won

Volltext

Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers von Sa, Jason K, Hwang, Jae Ryoung, Cho, Young-Jae, Ryu, Ji-Yoon, Choi, Jung-Joo, Jeong, Soo Young, Kim, Jihye, Kim, Myeong Seon, Paik, E Sun, Lee, Yoo-Young, Choi, Chel Hun, Kim, Tae-Joong, Kim, Byoung-Gie, Bae, Duk-Soo, Lee, Yeri, Her, Nam-Gu, Shin, Yong Jae, Cho, Hee Jin, Kim, Ja Yeon, Seo, Yun Jee, Koo, Harim, Oh, Jeong-Woo, Lee, Taebum, Kim, Hyun-Soo, Song, Sang Yong, Bae, Joon Seol, Park, Woong-Yang, Han, Hee Dong, Ahn, Hyung Jun, Sood, Anil K, Rabadan, Raul, Lee, Jin-Ku, Nam, Do-Hyun, Lee, Jeong-Won

Volltext

Altered MicroRNA Expression in Cervical Carcinomas von Lee, Jeong-Won, Choi, Chel Hun, Choi, Jung-Joo, Park, Young-Ae, Kim, Seung-Jun, Hwang, Seung Yong, Kim, Woo Young, Kim, Tae-Joong, Lee, Je-Ho, Kim, Byoung-Gie, Bae, Duk-Soo

Volltext

A multicentre, randomised, open-label, parallel-group Phase 2b study of belotecan versus topotecan for recurrent ovarian cancer von Kim, Hee Seung, Park, Sang-Yoon, Park, Chan-Yong, Kim, Young Tae, Kim, Beob-Jong, Song, Yong Jung, Kim, Byoung-Gie, Kim, Yong Beom, Cho, Chi-Heum, Kim, Jong-Hyeok, Song, Yong Sang

Volltext